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Abstract 
Integration of neurotransmitter and neuromodulator signals in the striatum plays a central role in the functions 
and dysfunctions of the basal ganglia. DARPP-32 is a key actor of this integration in the GABAergic medium-
size spiny neurons, in particular in response to dopamine and glutamate. When phosphorylated by cAMP-
dependent protein kinase (PKA) DARPP-32 inhibits protein phosphatase-1 (PP1), whereas when 
phosphorylated by cyclin-dependent kinase 5 (CDK5) it inhibits PKA. DARPP-32 is also regulated by casein 
kinases and by several protein phosphatases. These complex and intricate regulations make simple 
predictions of DARPP-32 dynamic behaviour virtually impossible. We used detailed quantitative modelling of 
the regulation of DARPP-32 phosphorylation to improve our understanding of its function. The models included 
all the combinations of the three best characterized  phosphorylation sites of DARPP-32, their regulation by 
kinases and phosphatases, and the regulation of those enzymes by cAMP and Ca2+  signals. Dynamic 
simulations allowed to observe the temporal relationships between cAMP and Ca2+  signals. We confirmed 
that the proposed regulation of protein phosphatase-2A (PP2A) by calcium can account for the observed 
decrease of Threonine 75 phosphorylation upon glutamate receptor activation. Sensitivity analysis showed 
that CDK5 activity is a major regulator of the response, as previously suggested. Conversely, the strength of 
the regulation of PP2A by PKA or by calcium, had little effect on the PP1-inhibiting function of DARPP-32 in 
these conditions. The simulations showed that DARPP-32 is not only a robust signal integrator, but that its 
response also depends on the delay between cAMP and calcium signals affecting the response to the latter. 
This integration did not depend on the concentration of DARPP-32, while the absolute effect  on PP1 varied 
linearly. In silico mutants showed that Ser137 phosphorylation affects the coincidence detector function, and 
that constitutive phosphorylation in Ser137 transforms DARPP-32 in a quasi-irreversible switch. This work is a 
first attempt to better understand the complex interactions between cAMP and Ca2+ regulation of DARPP-32. 
Progressive inclusion of additional components should lead to a realistic model of signalling networks 
underlying the function of striatal neurons.                                       
(PLoS Computational Biology, under revision.)
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Biological model of DARPP-32 regulation
The various endogenous external signals affecting DARPP-32 through 
cAMP and calcium are represented, as well as external drugs. A, nigro-
striatal medium-size spiny GABAergic neuron; B,  nigro-pallidal medium-
size spiny GABAergic neuron. Arrow-ending lines represent stimulation, 
bar-ending lines represent inhibition, circle-ending lines represent 
enzymatic reactions. Dashed lines represent reactions only present in 
model B. Grey reactions are not present in the model. Source: 
Svenningsson P, Nishi A, Fisone G, Girault J, Nairn AC et al. (2004) 
DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol 
Toxicol 44: 269-296 [Swenningston et al (2004)].
Biochemical model of DARPP-32 regulation
Graphical representation of the models implemented in this 
study. Arrow-ending lines represent transition, either 
phosphorylations or binding. Note that the bindings are 
reversible. Circle-ending lines represent enzymatic reactions 
The effects of kinases and phosphatases on DARPP-32 have 
been represented only once for clarity, but each couple of 
enzymes effectively acts on every pairs of arrows of the 
same colour. The different thickness of red arrows represent 
the catalytic rates for the various DARPP-32 species. Dashed 
lines represent reactions only present in model B. 
Effect of one pulse of cAMP 
followed by a train of Ca2+ 
spikes on DARPP-32 
phosphorylation
Time-course of DARPP-32 
isoforms triggered by a pulse of 
cAMP followed by a train of Ca2+ 
spikes. Relax and Thr34min show 
the two readouts used in 
sensitivity analysis. Panel A, 
model A; panel B, model B. 
Cross-sensitivity to the inhibition of PKA by DARPP-32 and the activity of CDK5 or the 
stimulation of PP2A by PKA
Values corresponding to model A are blue while values corresponding to model B are magenta. 
Panel A, cross-sensitivity to the inhibition of PKA by DARPP-32 and the activity of CDK5. Note the 
inverse relationship between CDK5 activity and Thr34min for strong inhibition of PKA (low kcat) 
while the relationship is reversed at weak inhibition. Panel B, cross-sensitivity to the inhibition of 
PKA by DARPP-32 and the stimulation of PP2A by PKA.
Effect of the delay between cAMP and calcium stimuli
Panel A, time-course of D34* in model B, triggered by a pulse of cAMP followed, after a variable 
delay, by a train of Ca2+ spikes. Panel B, relaxation time of DARPP-32 response to calcium in 
function of the delay between cAMP pulse and Ca2+  spikes. Green diamonds represent the 
response of “wild-type” DARPP-32 while red triangles represent the response of a mutant without 
Ser137 phosphorylation.
Effect of one pulse of cAMP 
followed by a train of Ca2+ 
spikes on DARPP-32 
phosphorylation
Time-course of DARPP-32 
isoforms triggered by a pulse of 
cAMP followed by a train of Ca2+ 
spikes. Relax and Thr34min show 
the two readouts used in 
sensitivity analysis. Panel A, 
model A; panel B, model B. 
Dependency of th signal 
integration on the 
concentration of DARPP-32
Same simulation paradigm than 
the one depicted in figure 5, but 
with different concentrations of 
DARPP-32, all the other 
parameters being conserved. 
Only D34* of model B is plotted. 
While the X axis remains the 
same for all time-course, the Y 
axis is scaled to superpose all the 
traces. The vertical scaling is 
roughly linear, that is a twofold 
increase between successive  
values of DARPP-32. Panel A, 
calcium spikes started 50 s after 
the pulse of cAMP; Panel B, 
calcium spikes started 200 s after 
the pulse of cAMP.
Mechanism of PKA inhibition by the DARPP-32 when 
phosphorylatie on threonine 75: competitive inhibition. Note 
that because there is no rebinding of the product, D34:75 and 
D34:75:137 do not inhibit PKA.
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In silico site-directed 
mutagenesis of DARPP-32
Same simulation paradigm than 
the one depicted in figure 5, but 
describing the predicted 
behaviour of mutants by model B. 
Wild-type DARPP-32 species are 
represented in green, Ser137Ala 
in red and constitutive Ser137P in 
blue. Panel A, D34*; Panel B 
D75*.
Modelling and simulation were performed using the E-cell system version 3 
[Takahashi et al  (2004). Bioinformatics 20: 538-546.]  release 3.1.103 
http://www.e-cell.org/). A generic ODEStepper developed by Kazunari Kaizu 
was used for the elementary reactions, combining different types of single-
step embedded Runge-Kuttas. XPP version 5.6 was also used to  test 
specific features of the models  [Ermentrout B (2002). Soc for Industrial & 
Applied Math] (http://www.math.pitt.edu/~bard/xpp/xpp.html) 
Authors thanks Denis Hervé for the discussions about DARPP-32 function 
and regulations, Kouichi Takahashi, Kazunari Kaizu and Gabor Bereczki for 
their help with E-Cell algorithms and interface, and Dominic Tolle for his 
insightful reading of the manuscript. Models A and B have been submitted to 
BioModels Database under the temporary accessions MODEL3492630792 
and MODEL3492674214 respectively.
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